NiKem Research (www.nikemresearch.com) entered into a research service deal with InterMune (www.intermune.com) related to pulmonology. In the next 12 months, NiKem will use its medicinal chemistry and early ADMET/PK platform and expertise to design, synthesize, and profile drug-like compounds aimed toward specific, undisclosed pulmonology targets of interest for InterMune.
